Florida Cancer Specialists & Research Institute First in Palm Beach County To Offer Targeted Radioligand Therapy for Metastatic Prostate Cancer
October 12, 2022 13:40 ET | Florida Cancer Specialists & Research Institute
Fort Myers, Fla., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute locations in Palm Beach County are now offering Pluvicto ™, the first targeted radioligand...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Novartis, Ebix, Intuit, and Argo and Encourages Investors to Contact the Firm
July 20, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, July 20, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Novartis AG (NYSE: NVS),...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Digital World, Generac, Novartis, and Cognyte and Encourages Investors to Contact the Firm
July 15, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Digital World Acquisition...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating the WWE, Digital World, Generac, and Novartis and Encourages Investors to Contact the Firm
July 10, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against World Wrestling...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Novartis, Unity Software, Gap, and Cassava and Encourages Investors to Contact the Firm
July 04, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, July 04, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Novartis AG (NYSE: NVS),...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Novartis, Medallion, RBB, and Agrify and Encourages Investors to Contact the Firm
June 24, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Novartis AG (NYSE: NVS),...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Novartis, and Corcept and Encourages Investors to Contact the Firm
June 13, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA),...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Novartis, and Corcept and Encourages Investors to Contact the Firm
June 08, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA),...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Enochian, Novartis, Teladoc, and Tupperware and Encourages Investors to Contact the Firm
June 03, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Enochian Biosciences, Inc....
Societal Color Logo and Tagline.png
Societal CDMO to Report Financial Results for First Quarter 2022 on May 11, 2022
May 04, 2022 16:05 ET | Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., May 04, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...